Concepedia

J Rudy

JR

Statistics

Publications

4

Citations

1K

H-Index

4

Active since

2013

Affiliations

Celladon Corporation (United States)(Current)

Imperial College London

Duke University

University of California San Diego

J Rudy is an author at Celladon Corporation (United States) specializing in heart failure, cardiology, and medicine.

Top concepts

Publications per year

2013–2020

4

Publications

4

Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial

Barry Greenberg, Javed Butler, G. Michael Felker et al. · The Lancet · 2016 · 492 citations · Full text

, , +9

Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure

Krisztina M. Zsebo, Alex Yaroshinsky, J Rudy et al. · Circulation Research · 2013 · 302 citations

Design of a Phase 2b Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Advanced Heart Failure

Barry Greenberg, Alex Yaroshinsky, Krisztina M. Zsebo et al. · JACC Heart Failure · 2014 · 150 citations

, , +8

Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device – the SERCA-LVAD TRIAL

Alexander R. Lyon, Daphne Babalis, Andrew Morley‐Smith et al. · Gene Therapy · 2020 · 85 citations · Full text

1–4 of 4